Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| METHODE ELECTRONICS INCMEI · Entity 1870 | Director | September 22, 2026 | September 24, 2026 |
| NEOGENOMICS INCNEO · Entity 2096 | Director | August 10, 2023 | August 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
METHODE ELECTRONICS INC
Report date September 22, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 9,186 |
Reported balance
After 2026-09-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-22 · Grant · Acquired 9,186 · Balance 9,186 F1: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan. F2: The restricted stock units vest in full on the date of the Company's 2027 annual meeting of shareholders. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust | 50,654 |
Reported balance
Holding disclosure · report date 2026-09-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 50,654 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan.
F2: The restricted stock units vest in full on the date of the Company's 2027 annual meeting of shareholders.
NEOGENOMICS INC
Report date August 10, 2023 · Filed August 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.82 · Expires 2033-08-10 | Direct | 8,353 |
Reported balance
After 2023-08-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-08-10 · Grant · Acquired 8,353 · Balance 8,353 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 11,336 |
Reported balance
After 2023-08-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-08-10 · Grant · Acquired 11,336 · Balance 11,336 F1: Once vested, the shares of common stock are not subject to expiration. |
| Common StockSEC Table I · non-derivative | Direct | 65,120 |
Reported balance
Holding disclosure · report date 2023-08-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 65,120 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.90 · Expires 2028-06-02 | Direct | 3,714 |
Reported balance
Holding disclosure · report date 2023-08-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 3,714 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.10 · Expires 2029-06-10 | Direct | 13,882 |
Reported balance
Holding disclosure · report date 2023-08-10 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 13,882 |
Filing footnotes · ownership attribution and instrument terms
F1: Once vested, the shares of common stock are not subject to expiration.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WINTRUST FINANCIAL CORP
Report date December 31, 2022 · Filed January 03, 2023
Section 16 reporting ended · disclosed 2023-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,545 |
Reported balance
After 2022-12-31 transaction · row 1
1 source rowRow 1 · 2022-12-31 · Grant · Acquired 686 · Balance 44,545 F1: Shares earned for the fourth quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares earned for the fourth quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2018 Filed Jan 3, 2019 21:26 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 365 | $84.94 | $31,003.10 |
DisclosureSEC source: 0001015328-19-000017 · wf-form4_154655075391114.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,623 F1 · shares: Shares earned for the fourth quarter of 2018 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| September 30, 2018 Filed Oct 1, 2018 20:13 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 356 | $87.05 | $30,989.80 |
DisclosureSEC source: 0001015328-18-000180 · wf-form4_153842482293625.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,258 F1 · shares: Shares earned for the third quarter of 2018 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:20 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 359 | $86.05 | $30,891.95 |
DisclosureSEC source: 0001015328-18-000143 · wf-form4_153064919557834.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 F1 · shares: Shares earned for the second quarter of 2018 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:48 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000045 · wf-form4_152823527318260.xml · derivative · entry 2 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:48 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000045 · wf-form4_152823527318260.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,766 Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 21:05 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 374 | $82.37 | $30,806.38 |
DisclosureSEC source: 0001015328-18-000091 · wf-form4_152278950490626.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,543 F1 · shares: Shares earned for the first quarter of 2018 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:32 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 373 | $78.31 | $29,209.63 |
DisclosureSEC source: 0001015328-18-000016 · wf-form4_151501514990781.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,169 F1 · shares: Shares earned for the fourth quarter of 2017 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 20:42 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 382 | $76.44 | $29,200.08 |
DisclosureSEC source: 0001015328-17-000183 · wf-form4_150697690742110.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,796 F1 · shares: Shares earned for the third quarter of 2017 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| July 21, 2017 Filed Jul 25, 2017 20:25 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | SaleCommon Stock | 323 | $76.99 | $24,867.77 |
DisclosureSEC source: 0001015328-17-000162 · wf-form4_150101429791791.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,414 Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 20:02 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 385 | $69.12 | $26,611.20 |
DisclosureSEC source: 0001015328-17-000139 · wf-form4_149911215790050.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,737 F1 · shares: Shares earned for the second quarter of 2017 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| May 30, 2017 Filed May 31, 2017 01:27 UTC | NEOGENOMICS INC NEO · Entity 2096 | ConversionRestricted Stock · Derivative | 5,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036318 · doc4.xml · derivative · entry 4 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,072 shares Expires 2017-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · kind: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F4 · derivative.exercise_date: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017. Read SEC document |
| May 30, 2017 Filed May 31, 2017 01:27 UTC | NEOGENOMICS INC NEO · Entity 2096 | ConversionRestricted Stock · Derivative | 2,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036318 · doc4.xml · derivative · entry 3 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,150 shares Expires 2017-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · kind: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F3 · derivative.exercise_date: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017. Read SEC document |
| May 30, 2017 Filed May 31, 2017 01:27 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon stock | 7,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036318 · doc4.xml · nonDerivative · entry 2 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 31, 2017 01:27 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantRestricted Stock · Derivative | 8,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036318 · doc4.xml · derivative · entry 8 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,667 Underlying: Common Stock · 8,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F8 · derivative.exercise_date: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018. F9 · derivative.expiration_date: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. Read SEC document |
| May 25, 2017 Filed May 31, 2017 01:27 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $7.27 Strike: $7.27 | $72,700.00 |
DisclosureSEC source: 0001209191-17-036318 · doc4.xml · derivative · entry 7 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-05-25 F7 · derivative.exercise_date: On May 25, 2017, Mr. Crowther was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 20:18 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 349 | $72.57 | $25,326.93 |
DisclosureSEC source: 0001015328-17-000103 · wf-form4_149125068745778.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,352 F1 · shares: Shares earned for the first quarter of 2017 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:17 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 444 | $55.57 | $24,673.08 |
DisclosureSEC source: 0001015328-17-000014 · wf-form4_148356461019637.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,003 F1 · shares: Shares earned for the fourth quarter of 2016 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 22:04 UTC | WINTRUST FINANCIAL CORP WTFC · Entity 3524 | GrantCommon Stock | 483 | $51.00 | $24,633.00 |
DisclosureSEC source: 0001015328-16-000397 · wf-form4_147553223334283.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,559 F1 · shares: Shares earned for the third quarter of 2016 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.